Thirty patients were discharged from hospital after treatment with arterial counterpulsation for acute severe heart failure complicating myocardial infarction. Seventeen patients had been in cardiogenic shock--13 with power failure alone, and 4 with a mechanical complication which required corrective surgery. Thirteen patients were in impending or 'preshock'. The follow-up period after infarcti...

The role of arterial counterpulsation was sought in 100 patients with severe refractory cardiac failure complicating myocardial infarction. Seventy-four were in shock and 26 were not. Average duration of counterpulsation was 7.0 days. Hospital survival was 34 per cent (25/74) in shock (predicted less than 10%) and 65 per cent in patients who were not in shock (predicted less than 50%). Survival...

BACKGROUND Mechanical circulatory support is a common practice nowadays in the management of patients after cardiogenic shock due to myocardial infarction. The single or combined use of one or more devices for mechanical support depends not only on the advantage or disadvantage of these devices but also on the timing of use of these devices before the development of multi organ failure. In our ...

The ion-intercalation materials used in high-energy batteries such as lithium-ion undergo large composition changes–which correlate to high storage capacity—but which also induce structural changes and stresses that can cause performance metrics such as power, achievable storage capacity, and life to degrade. “Electrochemical shock”–the electrochemical cyclinginduced fracture of materials–contr...

conclusions mortality from papillary muscle rupture remains elevated. survival largely depends on the early surgical repair or the replacement of the mitral valve. case presentation a 71-year-old woman presented to an outside hospital complaining of chest pain and shortness of breath. an electrocardiogram was obtained and revealed depression of the st segments from leads v1 to v4. troponin i wa...

Mechanical reperfusion for acute myocardial infarction cardiogenic shock (AMICS) has a class I A indication in both the American and European guidelines (1). Unfortunately, over the past 20 years, little progress has been made in improving outcomes since the pivotal SHOCK (Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock) trial was conducted (2). The recent Food and ...